Novo Nordisk | Beban Penjualan Dan Administrasi

Harga Saham
49.04
Perubahan Harian
-0.31 -0.63%
Bulanan
-17.99%
Tahunan
-41.47%
Q1 Perkiraan
45.26




Beban Penjualan Dan Administrasi Perubahan Tanggal
ANI Pharmaceuticals USD 76.66M 5.11M 2025-09
Aurora Cannabis CAD 41.79M 3.84M 2025-09
Bausch Health Companies USD 795M 99M 2025-09
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Canopy Growth CAD 29.53M 999K 2025-09
Corcept Therapeutics USD 106.97M 3.12M 2025-09
Drreddys Laboratories INR 26.92B 3.74B 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
Merck USD 2.85B 215M 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Novartis USD 3.31B 134M 2025-09
Novo Nordisk DKK 17.44B 1.41B 2025-12
Novo Nordisk DKK 2.86B 13.25B 2025-06
Pacira USD 91.8M 14.6M 2025-09
Perrigo USD 245.7M 27.4M 2025-09
Phibro Animal Health USD 76.34M 10.54M 2024-12
Prestige Brands USD 29.67M 1.64M 2025-12
Sanofi EUR 2.75B 455M 2025-12
Supernus Pharmaceuticals USD 179.68M 117.46M 2025-09
Zoetis USD 579M 29M 2025-09


Novo Nordisk Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Feb 2026.